Viking Therapeutics, Inc. isamba semali engenayo, imali engenayo yonke kanye nezinguquko zezinguquko eziguqwini US dollar namuhla
Viking Therapeutics, Inc. imali engenayo yamanje ku- US dollar. Viking Therapeutics, Inc. imali engenayo eseyi- -15 381 000 $. Nazi izinkomba eziphambili zezezimali ze- Viking Therapeutics, Inc.. Ishadi lombiko wezezimali kwiwebhusayithi yethu libonisa imininingwane ngezinsuku ukusuka 30/06/2017 to 30/06/2021. Viking Therapeutics, Inc. kugrafu ngesikhathi sangempela ukhombisa amandla, isb. Ushintsho empahleni ebekiwe yenkampani. Inani lawo wonke amafa we- Viking Therapeutics, Inc. igrafu ikhonjiswe luhlaza.
|
|
Usuku lokubika
|
Ingqikithi yenzuzo
Imali engenayo ibalwa ngokuphindaphinda ubuningi bezimpahla ezithengiswa ngentengo yezimpahla.
futhi
Ushintsho (%)
Ukuqhathaniswa kombiko wesinekota walo nyaka kanye nombiko wekota wonyaka odlule.
|
Imali engenayo
Imali engenayo iyinzuzo yebhizinisi ngaphandle kwezindleko zezimpahla ezithengisiwe, izindleko nezintela esikhathini sokubika.
futhi
Ushintsho (%)
Ukuqhathaniswa kombiko wesinekota walo nyaka kanye nombiko wekota wonyaka odlule.
|
|
30/06/2021 |
0 $ |
- |
-15 381 000 $ |
- |
|
31/03/2021 |
0 $ |
- |
-14 010 000 $ |
- |
|
31/12/2020 |
0 $ |
- |
-10 948 000 $ |
- |
|
30/09/2020 |
0 $ |
- |
-9 288 000 $ |
- |
|
30/09/2019 |
0 $ |
-
|
-5 731 000 $ |
-
|
|
30/06/2019 |
0 $ |
-
|
-7 674 000 $ |
-
|
|
31/03/2019 |
0 $ |
-
|
-4 924 000 $ |
-
|
|
31/12/2018 |
0 $ |
-
|
-5 240 000 $ |
-
|
|
30/09/2018 |
0 $ |
-
|
-6 600 000 $ |
-
|
|
30/06/2018 |
0 $ |
-
|
-6 672 000 $ |
-
|
|
31/03/2018 |
0 $ |
-
|
-3 551 000 $ |
-
|
|
31/12/2017 |
0 $ |
-
|
-4 084 473 $ |
-
|
|
30/09/2017 |
0 $ |
-
|
-6 099 658 $ |
-
|
|
30/06/2017 |
0 $ |
-
|
-5 171 634 $ |
-
|
|
|
Bonisa:
|
|
Ukuze
|
|
|
|
Umbiko wezezimali Viking Therapeutics, Inc., isimiso
Izinsuku ze- Viking Therapeutics, Inc.: 30/06/2017, 31/03/2021, 30/06/2021. Izinsuku zezitatimende zezezimali zinqunywa yimithetho yokubalwa kwezimali. Usuku lwakamuva lombiko wezezimali we Viking Therapeutics, Inc. yi 30/06/2021. Imali engenayo yokusebenza Viking Therapeutics, Inc. iyisilinganiso sokuphendula esilinganisa inani lemali etholakalayo emisebenzini yebhizinisi, ngemuva kokunciphisa izindleko zokusebenza, njengeholo, ukwehla kwenani kanye nezindleko zezimpahla ezithengiswayo. Imali engenayo yokusebenza Viking Therapeutics, Inc. kuyinto -15 541 000 $
|
|
|
Izinsuku zembiko yezimali Viking Therapeutics, Inc.
Imali engenayo Viking Therapeutics, Inc. iyinzuzo yebhizinisi ngaphandle kwezindleko zezimpahla ezithengisiwe, izindleko nezintela esikhathini sokubika. Imali engenayo Viking Therapeutics, Inc. kuyinto -15 381 000 $ Izindleko zokusebenza Viking Therapeutics, Inc. yizindleko ibhizinisi elizibandakanya ngenxa yokwenza imisebenzi yalo evamile yebhizinisi. Izindleko zokusebenza Viking Therapeutics, Inc. kuyinto 15 541 000 $ Imali yamanje Viking Therapeutics, Inc. yimali yonke imali egcinwe yinkampani ngosuku lombiko. Imali yamanje Viking Therapeutics, Inc. kuyinto 8 829 000 $
|
|
Ukulingana Viking Therapeutics, Inc. yinani lazo zonke izimpahla zomnikazi ngemuva kokukhipha izikweletu eziphelele kumpahla ephelele. Ukulingana Viking Therapeutics, Inc. kuyinto 224 974 000 $
|
|
30/06/2021
|
31/03/2021
|
31/12/2020
|
30/09/2020
|
30/09/2019
|
30/06/2019
|
31/03/2019
|
31/12/2018
|
30/09/2018
|
30/06/2018
|
31/03/2018
|
31/12/2017
|
30/09/2017
|
30/06/2017
|
|
|
Inzuzo enkulu
Inzuzo eyinzuzo yinzuzo eyenziwa yinkampani ngemuva kokunciphisa izindleko zokukhiqiza nokuthengisa imikhiqizo yayo kanye / noma izindleko zokuhlinzeka ngezinsizakalo zayo.
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Inani lentengo
Izindleko yizindleko eziphelele zokukhiqizwa nokusatshalaliswa kwemikhiqizo namasevisi yenkampani.
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Ingqikithi yenzuzo
Imali engenayo ibalwa ngokuphindaphinda ubuningi bezimpahla ezithengiswa ngentengo yezimpahla.
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Imali engenayo yokusebenza
Imali engenayo yokusebenza iyinzuzo evela ebhizinisini lenhloko yenkampani. Isibonelo, umthengisi udala imali engenayo ngokusebenzisa ukudayiswa kwezimpahla, kanti udokotela uthola inzuzo emisebenzini yezokwelapha ayinikezayo.
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Imali engenayo yokusebenza
Imali engenayo yokusebenza iyisilinganiso sokuphendula esilinganisa inani lemali etholakalayo emisebenzini yebhizinisi, ngemuva kokunciphisa izindleko zokusebenza, njengeholo, ukwehla kwenani kanye nezindleko zezimpahla ezithengiswayo.
|
-15 541 000 $ |
-14 228 000 $ |
-11 266 000 $ |
-9 843 000 $ |
-7 439 000 $ |
-9 569 000 $ |
-6 806 000 $ |
-7 037 000 $ |
-7 394 000 $ |
-6 925 000 $ |
-4 805 000 $ |
-4 427 252 $ |
-4 691 531 $ |
-4 982 743 $ |
|
Imali engenayo
Imali engenayo iyinzuzo yebhizinisi ngaphandle kwezindleko zezimpahla ezithengisiwe, izindleko nezintela esikhathini sokubika.
|
-15 381 000 $ |
-14 010 000 $ |
-10 948 000 $ |
-9 288 000 $ |
-5 731 000 $ |
-7 674 000 $ |
-4 924 000 $ |
-5 240 000 $ |
-6 600 000 $ |
-6 672 000 $ |
-3 551 000 $ |
-4 084 473 $ |
-6 099 658 $ |
-5 171 634 $ |
|
Izindleko ze-R & D
Izindleko zokucwaninga nezentuthuko - izindleko zocwaningo zokuthuthukisa imikhiqizo nezinqubo ezikhona noma ukuthuthukisa imikhiqizo nezinqubo ezintsha.
|
12 804 000 $ |
11 535 000 $ |
9 049 000 $ |
7 116 000 $ |
5 279 000 $ |
7 333 000 $ |
4 496 000 $ |
5 089 000 $ |
5 687 000 $ |
5 221 000 $ |
3 043 000 $ |
3 033 017 $ |
3 464 639 $ |
3 715 379 $ |
|
Izindleko zokusebenza
Izindleko zokusebenza yizindleko ibhizinisi elizibandakanya ngenxa yokwenza imisebenzi yalo evamile yebhizinisi.
|
15 541 000 $ |
14 228 000 $ |
11 266 000 $ |
9 843 000 $ |
7 439 000 $ |
9 569 000 $ |
6 806 000 $ |
7 037 000 $ |
7 394 000 $ |
6 925 000 $ |
4 805 000 $ |
4 427 252 $ |
4 691 531 $ |
4 982 743 $ |
|
Amafa wamanje
Izimpahla zamanje ziyingxenye yebhalansi emela ukubaluleka kwazo zonke izimpahla ezingashintshwa zibe yikheshi phakathi nonyaka owodwa.
|
237 662 000 $ |
249 863 000 $ |
256 104 000 $ |
263 134 000 $ |
289 256 000 $ |
293 644 000 $ |
299 137 000 $ |
302 133 000 $ |
306 616 000 $ |
144 258 000 $ |
78 731 000 $ |
21 851 798 $ |
11 525 074 $ |
14 264 002 $ |
|
Inani lempahla
Ingqikithi yempahla iyinani elilingana nengqikithi yenani eliphelele lenhlangano, amanothi esikweletu, nempahla ebonakalayo.
|
237 845 000 $ |
250 139 000 $ |
256 502 000 $ |
263 623 000 $ |
290 122 000 $ |
294 493 000 $ |
300 080 000 $ |
302 312 000 $ |
306 796 000 $ |
144 468 000 $ |
78 971 000 $ |
22 121 411 $ |
11 839 444 $ |
14 320 911 $ |
|
Imali yamanje
Imali yamanje yimali yonke imali egcinwe yinkampani ngosuku lombiko.
|
8 829 000 $ |
16 805 000 $ |
29 117 000 $ |
3 870 000 $ |
30 952 000 $ |
19 123 000 $ |
14 343 000 $ |
24 779 000 $ |
169 506 000 $ |
34 610 000 $ |
36 356 000 $ |
8 988 478 $ |
2 568 063 $ |
3 393 651 $ |
|
Isikweletu samanje
Isikweletu samanje siyingxenye yesikweletu esikhokhwa phakathi nonyaka (izinyanga ezingu-12) futhi siboniswa njengesibophezelo samanje kanye nengxenye yenani elisebenzayo.
|
- |
- |
- |
- |
6 192 000 $ |
5 626 000 $ |
4 918 000 $ |
4 550 000 $ |
- |
- |
3 758 000 $ |
3 450 540 $ |
3 180 411 $ |
3 050 427 $ |
|
Inani lemali
Ingqikithi yenkokhelo yinani lazo zonke imali enkampani enayo kuma-akhawunti ayo, kufaka phakathi imali encane nemali ebanjwe ebhange.
|
- |
- |
- |
- |
- |
- |
- |
- |
304 162 000 $ |
142 166 000 $ |
77 468 000 $ |
20 575 956 $ |
9 838 782 $ |
12 083 281 $ |
|
Isikweletu sonke
Ingqikithi yesikweletu iyinhlanganisela yesikweletu sesikhashana nesikhathi eside. Izikweleti zesikhashana esifushane yizo okufanele zibuyiselwe phakathi nonyaka. Isikweletu sesikhathi eside sihlanganisa zonke izikweletu okufanele zibuyiselwe ngemuva konyaka owodwa.
|
- |
- |
- |
- |
6 630 000 $ |
6 139 000 $ |
5 506 000 $ |
4 562 000 $ |
- |
- |
- |
- |
- |
- |
|
Isikweletu sesilinganiso
Ingqikithi yesamba semali ephelele yezimpahla yi-ratio yezezimali ekhombisa iphesenti yezimpahla zenkampani ezimele njengesikweletu.
|
- |
- |
- |
- |
2.29 % |
2.08 % |
1.83 % |
1.51 % |
- |
- |
- |
- |
- |
- |
|
Ukulingana
Ukulingana yinani lazo zonke izimpahla zomnikazi ngemuva kokukhipha izikweletu eziphelele kumpahla ephelele.
|
224 974 000 $ |
237 223 000 $ |
244 344 000 $ |
253 793 000 $ |
283 492 000 $ |
288 354 000 $ |
294 574 000 $ |
297 750 000 $ |
302 053 000 $ |
140 363 000 $ |
72 632 000 $ |
13 464 836 $ |
2 225 961 $ |
6 587 879 $ |
|
Ukugeleza kwemali
Ukugeleza kwezimali kuyinani eliphelele lemali kanye nezilinganiso zemali ezihamba enhlanganweni.
|
- |
- |
- |
- |
-3 398 000 $ |
-6 459 000 $ |
-3 152 000 $ |
-2 679 000 $ |
-5 503 000 $ |
-5 270 000 $ |
-5 303 000 $ |
-3 948 002 $ |
-3 328 003 $ |
-4 201 762 $ |
|
|
Umbiko wamuva wezezimali ngemali engenayo Viking Therapeutics, Inc. kwakungu-30/06/2021. Ngokombiko wamuva ngemiphumela yezezimali ye-Viking Therapeutics, Inc., imali engenayo ye-Viking Therapeutics, Inc. yayingu-0 US dollar futhi ishintshwe yaba ngu-0% uma kuqhathaniswa nonyaka odlule. Inzuzo enenetha ye Viking Therapeutics, Inc. engxenyeni yokugcina yayingu--15 381 000 $, inzuzo enenzuzo ishintshwe ngu-0% uma kuqhathaniswa nonyaka odlule.
|
